Literature DB >> 1570833

Pedigree and sib-pair linkage analysis suggest the apolipoprotein B gene is not the major gene influencing plasma apolipoprotein B levels.

J Coresh1, T H Beaty, P O Kwiterovich, S E Antonarakis.   

Abstract

Previous studies suggest that plasma apolipoprotein B-100 (apoB) level is strongly influenced by genetic factors. Characterizing alleles that influence plasma apoB level would help define genetic risk factors for coronary artery disease. This study examined the role of variability in the apolipoprotein B gene (APOB) in determining plasma apoB level. Twenty-three informative families from the Johns Hopkins Coronary Artery Disease Family Study were studied. Linkage analysis between three polymorphisms in the APOB gene (XbaI at codon 2488, MspI at codon 3611, and EcoRI at codon 4154) and a putative major gene with a codominant allele for elevated apoB levels gave evidence against linkage (LOD score of -7.9 at a recombination fraction of .001). None of the families had a LOD score greater than 0.5, while five families had a LOD score less than -0.5. Sib-pair analysis also showed no relationship between the proportion of genes identical by descent at the APOB locus and either crude or adjusted plasma apoB levels. Thus, in 23 informative families, there was no evidence for the presence, in APOB, of common alleles that influence plasma apoB levels. These results suggest that APOB is not the major locus influencing plasma apoB levels.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1570833      PMCID: PMC1682617     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  38 in total

1.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

2.  Serum lipids, lipoproteins and apolipoproteins in black patients with angiographically defined coronary artery disease.

Authors:  E S Ford; R S Cooper; B Simmons; A Castaner
Journal:  J Clin Epidemiol       Date:  1990       Impact factor: 6.437

3.  A mixed-model likelihood approximation on large pedigrees.

Authors:  S J Hasstedt
Journal:  Comput Biomed Res       Date:  1982-06

4.  Comparison of the plasma levels of apolipoproteins B and A-1, and other risk factors in men and women with premature coronary artery disease.

Authors:  P O Kwiterovich; J Coresh; H H Smith; P S Bachorik; C A Derby; T A Pearson
Journal:  Am J Cardiol       Date:  1992-04-15       Impact factor: 2.778

5.  Predictive value of lipoprotein (a) and other serum lipoproteins in the angiographic diagnosis of coronary artery disease.

Authors:  J A Hearn; S J DeMaio; G S Roubin; M Hammarstrom; D Sgoutas
Journal:  Am J Cardiol       Date:  1990-11-15       Impact factor: 2.778

6.  Hypervariability in a minisatellite 3' of the apolipoprotein B gene in patients with coronary heart disease compared with normal controls.

Authors:  W Friedl; E H Ludwig; B Paulweber; F Sandhofer; B J McCarthy
Journal:  J Lipid Res       Date:  1990-04       Impact factor: 5.922

7.  Association of coronary atherosclerosis with hyperapobetalipoproteinemia [increased protein but normal cholesterol levels in human plasma low density (beta) lipoproteins].

Authors:  A Sniderman; S Shapiro; D Marpole; B Skinner; B Teng; P O Kwiterovich
Journal:  Proc Natl Acad Sci U S A       Date:  1980-01       Impact factor: 11.205

8.  Association of hyperapobetalipoproteinemia with endogenous hypertriglyceridemia and atherosclerosis.

Authors:  A D Sniderman; C Wolfson; B Teng; F A Franklin; P S Bachorik; P O Kwiterovich
Journal:  Ann Intern Med       Date:  1982-12       Impact factor: 25.391

9.  Lipoproteins and apolipoproteins in young male survivors of myocardial infarction.

Authors:  N Al-Muhtaseb; N Hayat; M Al-Khafaji
Journal:  Atherosclerosis       Date:  1989-06       Impact factor: 5.162

10.  Lipoprotein and apoprotein values in coronary angiography patients.

Authors:  R G Kladetzky; G Assmann; S Walgenbach; P Tauchert; H D Helb
Journal:  Artery       Date:  1980
View more
  4 in total

1.  Complex genetic contribution of the Apo AI-CIII-AIV gene cluster to familial combined hyperlipidemia. Identification of different susceptibility haplotypes.

Authors:  G M Dallinga-Thie; M van Linde-Sibenius Trip; J I Rotter; R M Cantor; X Bu; A J Lusis; T W de Bruin
Journal:  J Clin Invest       Date:  1997-03-01       Impact factor: 14.808

2.  Genetic variation in lipoprotein (a) levels in families enriched for coronary artery disease is determined almost entirely by the apolipoprotein (a) gene locus.

Authors:  C A DeMeester; X Bu; R J Gray; A J Lusis; J I Rotter
Journal:  Am J Hum Genet       Date:  1995-01       Impact factor: 11.025

3.  Association of apolipoprotein E but not B with Alzheimer's disease.

Authors:  S E Poduslo; D Riggs; J Schwankhaus; A Osborne; F Crawford; M Mullan
Journal:  Hum Genet       Date:  1995-11       Impact factor: 4.132

4.  Diagnosis of families with familial hypercholesterolaemia and/or Apo B-100 defect by means of DNA analysis of LDL-receptor gene mutations.

Authors:  K Widhalm; A Dirisamer; A Lindemayr; G Kostner
Journal:  J Inherit Metab Dis       Date:  2007-03-08       Impact factor: 4.750

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.